190 related articles for article (PubMed ID: 38150993)
21. Disulfiram/Copper Induces Antitumor Activity against Both Nasopharyngeal Cancer Cells and Cancer-Associated Fibroblasts through ROS/MAPK and Ferroptosis Pathways.
Li Y; Chen F; Chen J; Chan S; He Y; Liu W; Zhang G
Cancers (Basel); 2020 Jan; 12(1):. PubMed ID: 31935835
[TBL] [Abstract][Full Text] [Related]
22. The Role of Ferroptosis and Cuproptosis in Curcumin against Hepatocellular Carcinoma.
Liu Z; Ma H; Lai Z
Molecules; 2023 Feb; 28(4):. PubMed ID: 36838613
[TBL] [Abstract][Full Text] [Related]
23. Sorafenib induces mitochondrial dysfunction and exhibits synergistic effect with cysteine depletion by promoting HCC cells ferroptosis.
Li Y; Xia J; Shao F; Zhou Y; Yu J; Wu H; Du J; Ren X
Biochem Biophys Res Commun; 2021 Jan; 534():877-884. PubMed ID: 33162029
[TBL] [Abstract][Full Text] [Related]
24. Disulfiram overcomes bortezomib and cytarabine resistance in Down-syndrome-associated acute myeloid leukemia cells.
Bista R; Lee DW; Pepper OB; Azorsa DO; Arceci RJ; Aleem E
J Exp Clin Cancer Res; 2017 Feb; 36(1):22. PubMed ID: 28143565
[TBL] [Abstract][Full Text] [Related]
25. Overcoming the compensatory increase in NRF2 induced by NPL4 inhibition enhances disulfiram/copper-induced oxidative stress and ferroptosis in renal cell carcinoma.
Ni X; Ye C; Yu X; Zhang Y; Hou Y; Zheng Q; Chen Z; Wang L; Weng X; Yang C; Liu X
Eur J Pharmacol; 2023 Dec; 960():176110. PubMed ID: 37838104
[TBL] [Abstract][Full Text] [Related]
26. Disulfiram/copper induces antitumor activity against gastric cancer cells in vitro and in vivo by inhibiting S6K1 and c-Myc.
Du C; Guan X; Liu Y; Xu Z; Du X; Li B; Wang M; Zheng Z
Cancer Chemother Pharmacol; 2022 Apr; 89(4):451-458. PubMed ID: 35201421
[TBL] [Abstract][Full Text] [Related]
27. Two clinical drugs deubiquitinase inhibitor auranofin and aldehyde dehydrogenase inhibitor disulfiram trigger synergistic anti-tumor effects in vitro and in vivo.
Huang H; Liao Y; Liu N; Hua X; Cai J; Yang C; Long H; Zhao C; Chen X; Lan X; Zang D; Wu J; Li X; Shi X; Wang X; Liu J
Oncotarget; 2016 Jan; 7(3):2796-808. PubMed ID: 26625200
[TBL] [Abstract][Full Text] [Related]
28. Disulfiram-loaded metal organic framework for precision cancer treatment via ultrasensitive tumor microenvironment-responsive copper chelation and radical generation.
Zhang H; Zhang Q; Guo Z; Liang K; Boyer C; Liu J; Zheng Z; Amal R; Yun SLJ; Gu Z
J Colloid Interface Sci; 2022 Jun; 615():517-526. PubMed ID: 35152072
[TBL] [Abstract][Full Text] [Related]
29. COMMD10 inhibits HIF1α/CP loop to enhance ferroptosis and radiosensitivity by disrupting Cu-Fe balance in hepatocellular carcinoma.
Yang M; Wu X; Hu J; Wang Y; Wang Y; Zhang L; Huang W; Wang X; Li N; Liao L; Chen M; Xiao N; Dai Y; Liang H; Huang W; Yuan L; Pan H; Li L; Chen L; Liu L; Liang L; Guan J
J Hepatol; 2022 May; 76(5):1138-1150. PubMed ID: 35101526
[TBL] [Abstract][Full Text] [Related]
30. Combination of the 6-thioguanine and disulfiram/Cu synergistically inhibits proliferation of triple-negative breast cancer cells by enhancing DNA damage and disrupting DNA damage checkpoint.
Chu M; An X; Zhang D; Li Q; Dai X; Yu H; Li Z
Biochim Biophys Acta Mol Cell Res; 2022 Feb; 1869(2):119169. PubMed ID: 34763028
[TBL] [Abstract][Full Text] [Related]
31. AdipoR1 Regulates Ionizing Radiation-Induced Ferroptosis in HCC cells through Nrf2/xCT Pathway.
Feng H; Liu Y; Gan Y; Li M; Liu R; Liang Z; Liu L; Li L; Chen H; Li G; Tian Z; Liu X; Ma S
Oxid Med Cell Longev; 2022; 2022():8091464. PubMed ID: 35733794
[TBL] [Abstract][Full Text] [Related]
32. Carrier-Free Self-Assembly Nano-Sonosensitizers for Sonodynamic-Amplified Cuproptosis-Ferroptosis in Glioblastoma Therapy.
Zhu Y; Niu X; Ding C; Lin Y; Fang W; Yan L; Cheng J; Zou J; Tian Y; Huang W; Huang W; Pan Y; Wu T; Chen X; Kang D
Adv Sci (Weinh); 2024 Apr; ():e2402516. PubMed ID: 38582500
[TBL] [Abstract][Full Text] [Related]
33. ATF4 promotes angiogenesis and neuronal cell death and confers ferroptosis in a xCT-dependent manner.
Chen D; Fan Z; Rauh M; Buchfelder M; Eyupoglu IY; Savaskan N
Oncogene; 2017 Oct; 36(40):5593-5608. PubMed ID: 28553953
[TBL] [Abstract][Full Text] [Related]
34. Antitumor effects of disulfiram/copper complex in the poorly-differentiated nasopharyngeal carcinoma cells via activating ClC-3 chloride channel.
Xu X; Xu J; Zhao C; Hou X; Li M; Wang L; Chen L; Chen Y; Zhu L; Yang H
Biomed Pharmacother; 2019 Dec; 120():109529. PubMed ID: 31606620
[TBL] [Abstract][Full Text] [Related]
35. Disulfiram causes selective hypoxic cancer cell toxicity and radio-chemo-sensitization via redox cycling of copper.
Falls-Hubert KC; Butler AL; Gui K; Anderson M; Li M; Stolwijk JM; Rodman SN; Solst SR; Tomanek-Chalkley A; Searby CC; Sheffield VC; Sandfort V; Schmidt H; McCormick ML; Wels BR; Allen BG; Buettner GR; Schultz MK; Spitz DR
Free Radic Biol Med; 2020 Apr; 150():1-11. PubMed ID: 32032663
[TBL] [Abstract][Full Text] [Related]
36. Drug repositioning of disulfiram induces endometrioid epithelial ovarian cancer cell death via the both apoptosis and cuproptosis pathways.
Gan Y; Liu T; Feng W; Wang L; Li LI; Ning Y
Oncol Res; 2023; 31(3):333-343. PubMed ID: 37305383
[TBL] [Abstract][Full Text] [Related]
37. Improving the Therapeutic Efficacy of Sorafenib for Hepatocellular Carcinoma by Repurposing Disulfiram.
Zhang G; Wang Y; Fuchs BC; Guo W; Drum DL; Erstad DJ; Shi B; DeLeo AB; Zheng H; Cai L; Zhang L; Tanabe KK; Wang X
Front Oncol; 2022; 12():913736. PubMed ID: 35912209
[TBL] [Abstract][Full Text] [Related]
38. Copper-Enriched Prussian Blue Nanomedicine for In Situ Disulfiram Toxification and Photothermal Antitumor Amplification.
Wu W; Yu L; Pu Y; Yao H; Chen Y; Shi J
Adv Mater; 2020 Apr; 32(17):e2000542. PubMed ID: 32162734
[TBL] [Abstract][Full Text] [Related]
39. Anti-cancer effects of disulfiram in head and neck squamous cell carcinoma via autophagic cell death.
Park YM; Go YY; Shin SH; Cho JG; Woo JS; Song JJ
PLoS One; 2018; 13(9):e0203069. PubMed ID: 30212479
[TBL] [Abstract][Full Text] [Related]
40. Disulfiram/copper-disulfiram Damages Multiple Protein Degradation and Turnover Pathways and Cytotoxicity is Enhanced by Metformin in Oesophageal Squamous Cell Carcinoma Cell Lines.
Jivan R; Damelin LH; Birkhead M; Rousseau AL; Veale RB; Mavri-Damelin D
J Cell Biochem; 2015 Oct; 116(10):2334-43. PubMed ID: 25846272
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]